These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32476051)

  • 1. Impact of Surfactants on Polymer Maintained Nifedipine Supersaturation in Aqueous Solution.
    Wang S; Liu C; Chen H; Zhu AD; Qian F
    Pharm Res; 2020 May; 37(6):113. PubMed ID: 32476051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate.
    Pui Y; Chen Y; Chen H; Wang S; Liu C; Tonnis W; Chen L; Serno P; Bracht S; Qian F
    Mol Pharm; 2018 Jul; 15(7):2754-2763. PubMed ID: 29782805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.
    Dahan A; Beig A; Ioffe-Dahan V; Agbaria R; Miller JM
    AAPS J; 2013 Apr; 15(2):347-53. PubMed ID: 23242514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct NMR Monitoring of Phase Separation Behavior of Highly Supersaturated Nifedipine Solution Stabilized with Hypromellose Derivatives.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2017 Jul; 14(7):2314-2322. PubMed ID: 28558250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Polymer Species on Maximum Aqueous Phase Supersaturation Revealed by Quantitative Nuclear Magnetic Resonance Spectroscopy.
    Ueda K; Moseson DE; Pathak V; Taylor LS
    Mol Pharm; 2021 Mar; 18(3):1344-1355. PubMed ID: 33595322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
    Qian F; Wang J; Hartley R; Tao J; Haddadin R; Mathias N; Hussain M
    Pharm Res; 2012 Oct; 29(10):2765-76. PubMed ID: 22315020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer Type Impacts Amorphous Solubility and Drug-Rich Phase Colloidal Stability: A Mechanistic Study Using Nuclear Magnetic Resonance Spectroscopy.
    Ueda K; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1352-1362. PubMed ID: 32097023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable-Temperature NMR Analysis of the Thermodynamics of Polymer Partitioning between Aqueous and Drug-Rich Phases and Its Significance for Amorphous Formulations.
    Ueda K; Higashi K; Moribe K; Taylor LS
    Mol Pharm; 2022 Jan; 19(1):100-114. PubMed ID: 34702040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Insight into Different Stabilization Mechanisms of Phenytoin Derivatives Supersaturation by HPMC and PVP.
    Otsuka N; Ueda K; Ohyagi N; Shimizu K; Katakawa K; Kumamoto T; Higashi K; Yamamoto K; Moribe K
    J Pharm Sci; 2015 Aug; 104(8):2574-82. PubMed ID: 26059285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
    Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
    Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions.
    Deshpande TM; Shi H; Pietryka J; Hoag SW; Medek A
    Mol Pharm; 2018 Mar; 15(3):962-974. PubMed ID: 29345955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA.
    Tao J; Sun Y; Zhang GG; Yu L
    Pharm Res; 2009 Apr; 26(4):855-64. PubMed ID: 19052850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size.
    Ueda K; Taylor LS
    J Control Release; 2021 Feb; 330():229-243. PubMed ID: 33340567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-Mediated Drug Supersaturation Controlled by Drug-Polymer Interactions Persisting in an Aqueous Environment.
    Chen Y; Pui Y; Chen H; Wang S; Serno P; Tonnis W; Chen L; Qian F
    Mol Pharm; 2019 Jan; 16(1):205-213. PubMed ID: 30452278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of aggregate formation between a non-ionic polymer and ionic surfactants: An isothermal titration calorimetric study.
    Patel SG; Bummer PM
    Int J Pharm; 2017 Jan; 516(1-2):131-143. PubMed ID: 27789368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study.
    Sakurai A; Sakai T; Sako K; Maitani Y
    Chem Pharm Bull (Tokyo); 2012; 60(4):459-64. PubMed ID: 22466729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Oral Bioavailability of Sorafenib by Optimizing the "Spring" and "Parachute" Based on Molecular Interaction Mechanisms.
    Liu C; Chen Z; Chen Y; Lu J; Li Y; Wang S; Wu G; Qian F
    Mol Pharm; 2016 Feb; 13(2):599-608. PubMed ID: 26709621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.